Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 2Supranuclear Palsy, Progressive 1Spinal Cord Injuries 1Prostatic Neoplasms 1Parkinson Disease 1Myasthenia Gravis 1Multiple System Atrophy 1Lewy Body Disease 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Fatigue 1Essential Tremor 1Carcinoma, Renal Cell 1Alzheimer Disease 1

Interventions

Sunitinib 145Nivolumab 144pembrolizumab 132Sorafenib 84Bevacizumab 77Everolimus 74cabozantinib 71pazopanib 65Axitinib 65Ipilimumab 62aldesleukin 52Magnetic Resonance Spectroscopy 45Cyclophosphamide 40Interleukin-2 38lenvatinib 37Specimen Handling 36Radiosurgery 36Interferon-alpha 32atezolizumab 30temsirolimus 27belzutifan 24Gemcitabine 23fludarabine phosphate 22avelumab 22Radiotherapy 19Interferon alpha-2 19Biopsy 18fludarabine 17durvalumab 17Nephrectomy 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × Neurofeedback × Clear all
NCT01740154 2018-12-06

Sunitinib Malate Related Fatigue in Patients With Metastatic Kidney Cancer

Case Comprehensive Cancer Center

Phase NA Terminated
13 enrolled 7 charts
Genitourinary

Carcinoma, Renal Cell, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡